Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis
Hepatitis Monthly: ,
12 (5); 312-314 Article Type: Editorial
February 6, 2012
March 13, 2012
H. Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis,
Online ahead of Print
The hepatic microRNA (miRNA), miR-122, is the most abundant miRNA within the liver, where it accounts for 70% of the total miRNA pool. It is known that miR-122, as an unusual host factor, increases the abundance of hepatitis C virus (HCV) RNA in HCV infection by binding directly to the 5’-UTR of the viral genome. Therefore, it has been suggested as a potential target for the treatment of hepatitis C. However, recent evidence shows that miR-122 decreases HBV replication through the inhibitory effect of p53 on HBV transcription, and consequently it acts as a tumor-suppressor through both a decrease in HBV replication and by directly targeting cyclin G1, as well as Wnt/beta-catenin, and NDRG3 pathways. This paper will brie?y discuss the underlying mechanisms for the dual role of miR-122 in viral hepatitis, and explains why therapeutic applications of miR-122 may differ based on the underlying disease.
Implication for health policy/practice/research/medical education: Mir-122 has been suggested as a candidate target for treatment of hepatitis C. This editorial briefly discusses the underlying mechanisms for the dual role of miR-122 in viral hepatitis, and explains why therapeutic applications of miR-122 may differ based on the underlying disease. Please cite this paper as: Sendi H. Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis. Hepat Mon. 2012;12(5): 312-4. DOI: 10.5812/hepatmon.6128
Copyright © 2012
Kowsar Corp. All rights reserved
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.